Showing results (421-430 of 758) with videos related to
Sort By:
Pageof 76
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2015
ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal ImpairmentErica Rurali, Federica Banterla, Roberta Donadelli, et al.Transplantation|May 24, 2008
Effect of seliciclib (CYC202, R-roscovitine) on lymphocyte alloreactivity and acute kidney allograft rejection in ratAnna Pezzotta, Marilena Mister, Giuseppe Monteferrante, et al.Internal and Emergency Medicine|August 31, 2023
Post-recovery impact of the second and third SARS-CoV-2 infection waves on healthcare resource utilization in Lombardy, ItalySergio Harari, Pier Mannuccio Mannucci, Alessandro Nobili, et al.Nephron. Experimental Nephrology|August 12, 2006
Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is startedAriela Benigni, Carla Zoja, Marco Campana, et al.Journal of Internal Medicine|April 4, 2022
Impact of the post-COVID-19 condition on health care after the first disease wave in LombardyPier M Mannucci, Alessandro Nobili, Mauro Tettamanti, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|May 7, 2011
Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantationSistiana Aiello, Paola Cassis, Marilena Mister, et al.Journal of the American Society of Nephrology : JASN|April 1, 2005
Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvementMarina Noris, Sara Bucchioni, Miriam Galbusera, et al.Nature Reviews. Disease Primers|November 24, 2017
Chronic kidney diseasePaola Romagnani, Giuseppe Remuzzi, Richard Glassock, et al.Internal and Emergency Medicine|June 14, 2023
Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, ItalyPier Mannuccio Mannucci, Alessia Antonella Galbussera, Barbara D'Avanzo, et al.Kidney International|July 17, 2019
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathyPaola Cassis, Monica Locatelli, Daniela Corna, et al.Pageof 76